ArticleAmerican journal of cancer research2016

In vitro and in vivo antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathways.

Xueping Lei et al.PubMed ↗Full text ↗

No numbers read from the abstract.